<DOC>
	<DOCNO>NCT01675700</DOCNO>
	<brief_summary>The purpose study determine whether topical nitroglycerine patch apply daily trapezius trigger point improve patient ' symptom . If improvement , open label study help determine degree improvement contribute design large double blind placebo control trial . We would consider move forward large randomize trial : - The intervention acceptable patient ( &gt; = 70 % ) - Compliance satisfactory ( &gt; =80 % ) - We find preliminary evidence efficacy , i.e . average reduction pain 20mm VAS .</brief_summary>
	<brief_title>Topical Nitrates Myofascial Trigger Points</brief_title>
	<detailed_description />
	<mesh_term>Nitroglycerin</mesh_term>
	<criteria>Inclusion criterion include age 19 65 year old , myofascial pain last least 6 month , myofascial trigger point point trapezius muscle . Our exclusion criterion include symptomatic disc herniation , symptomatic cervical osteoarthritis , systemic infection , malignancy , collapse vertebra , thoracic outlet syndrome , temporomandibular joint dysfunction , collagenvascular disease , brachial plexopathy . Patients ongoing litigation regard symptom eligible study . Also exclude patient underlie cardiac disease , hypotension , medical condition may allow tolerate use vasodilator , use phosphodiesterase inhibitor .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Myofascial pain</keyword>
	<keyword>Trigger point</keyword>
	<keyword>Nitroglycerin</keyword>
</DOC>